Nuvation Bio Inc

Inside Nuvation Bio: insider trades reveal confidence as robust ROS1, IDH1 and DDC pipelines hit breakthrough milestones and safety targets, poised for 2026 FDA approvals.

Insider executives at Nuvation are buying millions of options, driving a 967% social‑media spike and a +90 sentiment score—signaling confidence ahead of Phase II data release.